Key terms

About KRYS

Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest KRYS news

Apr 16 6:50am ET Krystal Biotech price target raised to $204 from $178 at Stifel Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today Feb 28 11:59am ET Biotech Alert: Searches spiking for these stocks today Feb 28 11:59am ET Biotech Alert: Searches spiking for these stocks today Feb 27 9:24am ET Krystal Biotech price target raised to $168 from $140 at BofA Feb 27 8:37am ET Krystal Biotech price target raised to $175 from $130 at Guggenheim Feb 27 7:24am ET Krystal Biotech price target raised to $208 from $160 at TD Cowen Feb 27 6:51am ET Krystal Biotech price target raised to $195 from $160 at Citi Feb 27 6:07am ET Krystal Biotech price target raised to $200 from $139 at H.C. Wainwright Feb 27 6:02am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Krystal Biotech (KRYS) and Bristol-Myers Squibb (BMY) Feb 27 1:02am ET New Sales & Marketing Risk for Krystal Biotech, Inc. – What’s the Latest? Feb 26 8:35pm ET Buy Rating for Krystal Biotech Amidst Strong Vyjuvek Sales and Sizable Market Opportunity Feb 26 8:06am ET Krystal Biotech sees 2024 non-GAAP R&D, SG&A expense $150M-$175M Feb 26 8:05am ET Krystal Biotech reports Q4 EPS 30c, consensus (38c) Feb 08 7:06am ET Krystal Biotech announces publication in NEJM on application of B-VEC Feb 02 8:11am ET Krystal Biotech added to ‘Tactical Outperform’ list at Evercore ISI Jan 25 7:26am ET Stifel Nicolaus Keeps Their Buy Rating on Krystal Biotech (KRYS)

No recent press releases are available for KRYS

KRYS Financials

1-year income & revenue

Key terms

KRYS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

KRYS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms